CRIS Current Research Information System

COLAROSSI, SABRINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.419
AS - Asia 1.174
EU - Europa 997
AF - Africa 82
SA - Sud America 54
OC - Oceania 1
Totale 3.727
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.398
CN - Cina 302
SG - Singapore 300
VN - Vietnam 258
GB - Regno Unito 257
SE - Svezia 174
IT - Italia 110
DE - Germania 98
JP - Giappone 85
HK - Hong Kong 69
FR - Francia 61
IN - India 55
UA - Ucraina 54
NL - Olanda 50
RU - Federazione Russa 39
BR - Brasile 38
IE - Irlanda 37
TG - Togo 25
KR - Corea 23
CI - Costa d'Avorio 22
FI - Finlandia 22
ZA - Sudafrica 21
JO - Giordania 20
BG - Bulgaria 19
GR - Grecia 15
CA - Canada 14
EE - Estonia 14
BE - Belgio 12
CH - Svizzera 12
PL - Polonia 10
AR - Argentina 9
PH - Filippine 9
SC - Seychelles 7
IR - Iran 6
BD - Bangladesh 5
ES - Italia 5
ID - Indonesia 5
IQ - Iraq 5
NG - Nigeria 5
SA - Arabia Saudita 5
MX - Messico 4
PK - Pakistan 4
TR - Turchia 4
AT - Austria 3
CL - Cile 3
TH - Thailandia 3
TW - Taiwan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
EG - Egitto 2
LB - Libano 2
PY - Paraguay 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
IL - Israele 1
KG - Kirghizistan 1
LT - Lituania 1
MN - Mongolia 1
MT - Malta 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
Totale 3.727
Salva come PNG Salva come JPEG
Città #
Southend 227
Singapore 218
Chandler 215
Fairfield 123
Ashburn 116
Tokyo 76
Hong Kong 65
Houston 65
Woodbridge 58
Hefei 57
Ho Chi Minh City 56
Wilmington 56
Cambridge 49
San Jose 49
Seattle 49
New York 44
Hanoi 42
Santa Clara 42
Ann Arbor 41
Princeton 41
Beijing 39
Dublin 37
Jacksonville 36
Boardman 29
Dallas 27
Lomé 25
Abidjan 22
Turin 22
Helsinki 21
Westminster 21
Amman 20
Nanjing 19
Sofia 19
Seoul 18
Lauterbourg 17
Padova 17
Da Nang 13
Brussels 12
Buffalo 11
Los Angeles 11
Bern 10
Medford 10
Nanchang 10
Warsaw 10
Haiphong 9
Jinan 9
Orem 9
Saint Petersburg 9
San Diego 9
Shenyang 9
Falkenstein 8
Florence 8
Toronto 8
Bologna 7
Haikou 7
Milan 7
Bengaluru 6
Changsha 6
Guangzhou 6
Hangzhou 6
Tianjin 6
Berlin 5
Frankfurt am Main 5
Hebei 5
Mahé 5
Munich 5
Shanghai 5
São Paulo 5
Taizhou 5
Baghdad 4
Can Tho 4
Chiyoda-ku 4
Jiaxing 4
Johannesburg 4
Olalla 4
Phoenix 4
Redmond 4
Zhengzhou 4
Abeokuta 3
Amsterdam 3
Andover 3
Atlanta 3
Bexley 3
Bremen 3
Brooklyn 3
Chandigarh 3
Des Moines 3
Grafing 3
Ha Long 3
Hamamatsu 3
Istanbul 3
Mountain View 3
Mülheim 3
Ninh Bình 3
Qingdao 3
Quận Bình Thạnh 3
Redondo Beach 3
Taiyuan 3
Thái Bình 3
Verona 3
Totale 2.436
Salva come PNG Salva come JPEG
Nome #
Efficacy and Clinical Outcome of Philadelphia (Ph) Positive Acute Lymphoblastic Leukemia (ALL) Patients Treated with Second Generation Tyrosine Kinase Inhibitors (TKIs): The Bologna Experience 351
Dual Src/Abl inhibitor SKI-606 binding mode in BCR-ABL kinase hypothesized on the basis of molecular docking studies 300
Binding Mode Of The Novel Dual SRC and ABL Inhibitor SKI-606 To The BCR-ABL Kinase As Predicted By Molecular Docking Studies 289
Efficacy and clinical outcome of Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL) patients treated with second generation tyrosine kinase inhibitors (TKIs): The Bologna experience 257
Ultra-deep sequencing (uds) allows more sensitive detection of the D816V and other kit gene mutations in systemic mastocytosis 201
Ultra-Deep Sequencing (UDS) Allows More Sensitive Detection of the D816V and Other Kit Gene Mutations in Systemic Mastocytosis 194
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. 191
Philadelphia-positive patients who already harbour imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors. 186
Contribution Of ABL Kinase Domain Mutations To Imatinib Resistance In Different Subsets Of Philadelphia-Positive Patients. By The GIMEMA Working Party On Chronic Myeloid Leukemia 179
Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders. 167
Imatinib Mesylate Determines a High Frequency of Major Molecular Responses in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Phase Chronic Myeloid Leukemia on Behalf of the GIMEMA CML WP. 167
Ultra-Deep Sequencing (UDS) allows more sensitive detection of the D816V and other kit gene mutations in systemic mastocytosis 164
Second-line treatment with dasatinib in patients resistant to imatinib can select novel inhibitor-specific BCR-ABL mutants in Ph+ ALL 163
Presence or the Emergence of a F317L BCR-ABL Mutation May Be Associated With Resistance to Dasatinib in Philadelphia Chromosome Positive Leukemia 162
Low level mutations in the Bcr-Abl kinase domain may already be detected at diagnosis both in patients with Philadelphia-positive acute lymphoblastic leukemia and in patients with chronic phase chronic myeloid leukemia 157
Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP) 133
New drugs to overcome meccanisms of resistance in Ph+ leukemia: Bosutinib 124
Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain 114
null 104
Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis 101
null 85
Totale 3.789
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.165
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.165
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021111 0 0 0 0 0 0 0 0 0 17 12 82
2021/2022428 22 5 29 48 40 32 8 18 26 26 76 98
2022/2023624 83 130 23 77 37 49 14 30 98 12 57 14
2023/2024227 5 22 6 12 17 105 25 9 5 3 12 6
2024/2025452 12 67 33 33 59 35 18 19 2 63 26 85
2025/2026973 85 82 109 57 172 56 87 35 202 88 0 0
Totale 3.789